<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">Fungal infections</z:e> represent a life-threatening complication for patients receiving chemotherapy or undergoing hematopoietic stem cell transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Historically, antifungal monotherapy is associated with a poor outcome </plain></SENT>
<SENT sid="2" pm="."><plain>We treated three children with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> and proven <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (one cerebral mold <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, one disseminated <z:e sem="disease" ids="C0006840" disease_type="Disease or Syndrome" abbrv="">Candida infection</z:e>, one naso-pharyngeal mucor <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>) with combination antifungal therapy plus granulocyte-colony-stimulation-factor-mobilized granulocyte transfusions as secondary prophylaxis during subsequent neutropenic episodes </plain></SENT>
<SENT sid="3" pm="."><plain>With this approach, the <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> was effectively treated, and the anticancer therapy was completed without major delay </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> children survived the <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> and the underlying <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These experiences illustrate the feasibility of this approach using more than one <z:chebi fb="0" ids="35718">antifungal agent</z:chebi> together with immune-therapy in high-risk patients </plain></SENT>
</text></document>